clopidogrel and Lymphopenia

clopidogrel has been researched along with Lymphopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, MD; Bergmeier, W; Boulaftali, Y; Campbell, RA; Caron, KM; Casari, C; Chan, ER; Getz, TM; Kechele, DO; Mackman, N; Parrott, MC; Paul, DS; Peters, LL; Piatt, R; Robledo, RF; Stefanini, L; Weyrich, AS	1

Other Studies

1 other study(ies) available for clopidogrel and Lymphopenia

Article	Year
RASA3 is a critical inhibitor of RAP1-dependent platelet activation. The Journal of clinical investigation, 2015, Volume: 125, Issue:4 Topics: Animals; Cellular Senescence; Clopidogrel; GTPase-Activating Proteins; Guanine Nucleotide Exchange Factors; Hemostasis; Lymphopenia; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Platelet Activation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; rap1 GTP-Binding Proteins; Receptors, Purinergic P2Y12; Saphenous Vein; Splenectomy; Thrombocytopenia; Thrombopoiesis; Ticlopidine	2015

Article

Year

RASA3 is a critical inhibitor of RAP1-dependent platelet activation.

The Journal of clinical investigation, 2015, Volume: 125, Issue:4

Topics: Animals; Cellular Senescence; Clopidogrel; GTPase-Activating Proteins; Guanine Nucleotide Exchange Factors; Hemostasis; Lymphopenia; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Platelet Activation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; rap1 GTP-Binding Proteins; Receptors, Purinergic P2Y12; Saphenous Vein; Splenectomy; Thrombocytopenia; Thrombopoiesis; Ticlopidine

2015